| CORP. SALE | Imidazopyridine deriv |
| CLASSIFICATION | CommPat. Market |
| MARKETER'S COUNTRY | France |
| MECHANISM OF ACTION | BZD1 (GAGA-Omega) Receptor agonist |
| PATENT ASSIGNEE'S COUNTRY | France |
| PRODUCER'S COUNTRY | France |
| PROPERTIES |
In men, the drug reduces time for sleep appearance, reduces number of night wake-ups & increases sleep duration. It prolongs sleep stage II as well as deep sleep stages III & IV. It does not have effect on total paradoxal sleep time (REM phase). After 28 days of adm of daily dose of 10 mg; there shows no dependency |
| STATUS | Patent close to expiration |
| MARKETING BY | This data is not available for free |
| PATENT ASSIGNEE | This data is not available for free |
| PATENT PHOTOCOPY | Available on request |
| PRODUCTION BY | This data is not available for free |
| TRADEMARK | This data is not available for free |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |